Skip to content

Precigen

US · PGEN #2527 by market cap Listed 1970
4.21 +0.05 +1.20%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 4.12 -0.96%
After-hours 4.24 +0.61%
8.563.574.212026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on PGEN?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -17.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 12.5% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days B → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall D

The radar needs all six factors. Available grades are shown below.

Valuation D+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 38.3x Better than 14%
Forward P/E 8.4x Better than 89%
Price / Sales 10.4x Better than 10%
P/E vs own 5-yr range 100th pctl Better than 2%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability D

How much profit the business keeps from each dollar of sales and capital.

Gross margin 50.2% Better than 63%
Operating margin -1,100.8% Better than 3%
Net margin -4,436.6% Better than 1%
Return on equity -1,446.0% Better than 0%
Return on invested capital -525.7% Better than 0%
Momentum C+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -41.5% Better than 9%
6-month return -0.7% Better than 54%
12-month return (ex latest month) 64.7% Better than 89%
Distance below 52-week high 53.1% Better than 16%
Financial Health D

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.1x Better than 74%
Debt to assets 63.2% Better than 7%
Interest coverage -63.8x Better than 6%
Analyst View A+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 232.5% Better than 96%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.27%
1M -38.36%
3M -43.41%
6M -1.41%
YTD +0.72%
1Y +7.95%
3Y +247.93%
5Y +11.97%

Key statistics

Price & volume

Prev close
4.16
Open
4.16
Day range
4.07 - 4.36
Avg price
4.22
Volume
6.07M
Turnover
25.60M
Amplitude
6.97%
52-week range
3.04 - 8.98

Valuation

P/E
-3.07
P/E (TTM)
38.27
P/B
17.99
EPS
-1.37
Net profit
-491.21M
Net assets
83.90M

Share structure

Market cap
1.51B
Float cap
821.43M
Shares out
358.55M
Float shares
195.12M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 20% of range
3.04 8.98

53.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-12.84M net over the window

Short interest

Shares short
44.91M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Precigen (PGEN)?

Precigen last traded at 4.21. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Precigen's market cap?

About 1.51B.

What is the P/E ratio of Precigen?

The trailing twelve-month P/E is 38.27. The Valuation tab shows it against the stock's own five-year range.

Does Precigen pay a dividend?

Precigen does not currently pay a regular dividend.

Is Precigen a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 14.00, which implies 232.5% upside from the current price. This is not investment advice.

What is Precigen's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Precigen a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Precigen discussion 0 comments

Add a comment